Inventor · disambiguated record
Jason Fewell
Also filed as: FEWELL JASON · FEWELL JASON G · FEWELL JASON GLENN
15 granted patents·9 pending applications·449 citations·filing 2002–2021
93Inventor score
Top patents by PatentIndex Score
24 records- 0195US8460696B2Polyamine derivativesSLOBODKIN GREGORY·Filed 2010·Granted Jun 11, 2013·128 cites·22 claims
- 0295US8057821B2Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereofSLOBODKIN GREGORY·Filed 2004·Granted Nov 15, 2011·116 cites·15 claims
- 0394US7964571B2Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseasesEGEN INC·Filed 2005·Granted Jun 21, 2011·75 cites·37 claims
- 0492US7173116B2Nucleic acid formulations for gene delivery and methods of useGENETRONICS BIOMEDICAL CORP·Filed 2002·Granted Feb 6, 2007·88 cites·35 claims
- 0588US8445017B2Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereofSLOBODKIN GREGORY·Filed 2011·Granted May 21, 2013·6 cites·24 claims
- 0684US8623837B2Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseasesFEWELL JASON G·Filed 2011·Granted Jan 7, 2014·11 cites·20 claims
- 0784US7491537B2Nucleic acid formulations for gene delivery and methods of useGENETRONICS BIOMEDICAL CORP·Filed 2006·Granted Feb 17, 2009·4 cites·47 claims
- 0883US8569065B2Compositions and methods for the delivery of biologically active RNAsPOLACH KEVIN·Filed 2010·Granted Oct 29, 2013·11 cites·30 claims
- 0973US9468687B2Immuno gene therapy for treatment of cancer and hyperproliferative diseasesCLSN LABORATORIES INC·Filed 2014·Granted Oct 18, 2016·2 cites·13 claims
- 1072US7579326B2Gene switch systems employing regulators with decreased dimerizationGENETRONICS INC·Filed 2003·Granted Aug 25, 2009·5 cites·50 claims
- 1169US9144546B2Nucleic acid-lipopolymer compositionsMATAR MAJED·Filed 2012·Granted Sep 29, 2015·1 cites·20 claims
- 1269US8932638B2Polyamine derivativesCLSN LAB INC·Filed 2013·Granted Jan 13, 2015·1 cites·15 claims
- 1369US8900621B2Polyamine derivativesCLSN LAB INC·Filed 2013·Granted Dec 2, 2014·1 cites·8 claims
- 1462US2009042829A1Nucleic Acid-Lipopolymer CompositionsMATAR MAJED·Filed 2008·Application pending·0 cites
- 1560US9254334B2Polyamine derivativesCLSN LAB INC·Filed 2014·Granted Feb 9, 2016·0 cites·20 claims
- 1660US2010004313A1Modified Poloxamers for Gene Expression and Associated MethodsTBD·Filed 2009·Application pending·0 cites
- 1759US2018303957A1Nucleic acid-lipopolymer compositionsCLSN LABORATORIES INC·Filed 2017·Application pending·0 cites
- 1858US9827331B2Nucleic acid-lipopolymer compositionsCLSN LABORATORIES INC·Filed 2015·Granted Nov 28, 2017·0 cites·28 claims
- 1955US2025213679A1Polynucleotide vaccines and methods of using the sameCELSION CORP·Filed 2021·Application pending·0 cites
- 2051US2009042825A1Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymerMATAR MAJED·Filed 2007·Application pending·0 cites
- 2149US2010004315A1Biodegradable Cross-Linked Branched Poly(Alkylene Imines)SLOBODKIN GREGORY·Filed 2009·Application pending·0 cites
- 2248US2014005254A1Compositions and methods for the Delivery of Biologically Active RNAsEGEN INC·Filed 2013·Application pending·0 cites
- 2337US2013164845A1Compositions and Methods for the Delivery of Biologically Active RNAsPOLACH KEVIN·Filed 2012·Application pending·0 cites
- 2435US2016331686A1Compositions and Methods for Yeast Extracellular Vesicles as Delivery SystemsCLSN LABORATORIES INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →